Lonza Selects IDBS to Optimize Bioprocess Execution & Knowledge Management
News Jan 05, 2011
"We believe that adopting IDBS's Bioprocess Execution System as our data management solution will help us improve our processes and enhance the quality of the services we provide to customers," said Dr. Steve Flatman, Head of Mammalian Development Services. "After due consideration the IDBS software and service offering was our preferred solution. The knowledge and expertise of IDBS staff in the bioscience arena was a key factor in our decision."
Due to the complex nature of biopharmaceutical processes, pharmaceutical companies invest considerable time and money generating high-value data throughout the development lifecycle. This information is often locked in paper records or isolated electronic files, across multiple locations and in different formats, making it difficult to manage and analyze process data efficiently. As a result, organizations such as Lonza are turning to data management systems to integrate and optimize bioprocess workflows. This enables management of the complete laboratory-to-report lifecyle within one system, and makes data retrievable by scientists to help in targeting process optimizations. This, in turn, will assist the drive for operational excellence, a core part of Lonza's strategy.
"IDBS continues to develop informatics solutions that address the critical business needs of high value R&D and manufacturing activities," said Neil Kipling, founder and CEO of IDBS. "We believe that the bioprocess sector is an area of considerable growth and will benefit from our broad expertise and industry experience. We are delighted to be working with such an innovative company as Lonza, one of the first contract manufacturers to adopt our approach to process and knowledge management."
Cow Antibodies Yield Important Clues For Developing A Broadly Effective AIDS VaccineNews
The unexpected animal model is providing clues for important questions at a moment when new energy has infused HIV vaccine research.READ MORE
Cell Recycling System Offers Therapeutic Entry Point for Rare Disease TreatmentNews
Scientists have demonstrated how an investigational drug works against a rare, fatal genetic disease, Niemann-Pick type C1 (NPC1).READ MORE